ARQT vs ECL
Arcutis Biotherapeutics Inc (ARQT) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ARQT revenue for 2024-12-31 was $196.5M. Net income was -$140.0M. Revenue was up 229.7% from 2023-12-31 to 2024-12-31. ARQT currently screens at market cap $1.64B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ARQT currently screens at market cap $1.64B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ARQT and ECL stock pages for the full models.
Not investment advice.